BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright ©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Feb 27, 2026; 18(2): 113686
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.113686
Epstein-Barr virus infection in children with liver transplantation
Norrapat Onpoaree, Nattinee Leelakanok, Anapat Sanpavat, Palittiya Sintusek
Norrapat Onpoaree, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand
Nattinee Leelakanok, Department of Radiology and Biomedical Imaging, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand
Anapat Sanpavat, Department of Pathology, Chulalongkorn University, Bangkok 10330, Thailand
Palittiya Sintusek, Center of Excellence in Thai Pediatric Gastroenterology, Hepatology and Immunology, Division of Gastroenterology, Department of Pediatrics, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok 10330, Thailand
Author contributions: Onpoaree N and Sintusek P reviewed the literature and wrote the manuscript; Leelakanok N interpreted the radiological data and provided the radiological images; Sanpavat A interpreted the histopathological data and provided the histopathology images; Sintusek P provided the endoscopic images; all authors approved the final manuscript.
Conflict-of-interest statement: The authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Palittiya Sintusek, MD, PhD, Associate Professor, Center of Excellence in Thai Pediatric Gastroenterology, Hepatology and Immunology, Division of Gastroenterology, Department of Pediatrics, King Chulalongkorn Memorial Hospital, Chulalongkorn University, 1873 Rama IV, Pathumwan, Bangkok 10330, Thailand. palittiya.s@chula.ac.th
Received: September 1, 2025
Revised: September 28, 2025
Accepted: December 16, 2025
Published online: February 27, 2026
Processing time: 165 Days and 1.5 Hours
Abstract

Epstein-Barr virus (EBV) infection commonly occurs in children, particularly in developing countries. Most children infected with EBV are asymptomatic, though some develop significant complications, including EBV-associated malignancies, hemophagocytic lymphohistiocytosis, and multiple sclerosis. In immunocompromised children, including those with liver transplantation, EBV infection manifests with a diverse spectrum of presentations, varying from asymptomatic to post-transplant lymphoproliferative disorder, which can evolve into lymphoma. Therefore, close monitoring, early detection, and prompt management are crucial. This review aimed to investigate the pathogenesis and manifestations of EBV in healthy children and those who underwent liver transplantation. The proposed algorithm for early EBV detection and management, along with case studies, is provided to help pediatricians increase their index of suspicion.

Keywords: Epstein-Barr virus; Liver transplantation; Infection; Children; Post-transplant lymphoproliferative disorder; Lymphoma; Pediatric; Immunosuppressive drug; Immunocompromised; Rituximab

Core Tip: Epstein-Barr virus (EBV) infection is common and can cause serious complications in pediatric liver transplant recipients. Young children who are EBV-seronegative are at especially increased risk because primary infection or viral reactivation may progress to post-transplant lymphoproliferative disorder. Routine EBV viral load monitoring, timely immunosuppressive therapy adjustment, and early intervention are crucial to reduce morbidity and mortality. A deeper understanding of EBV pathogenesis, combined with individualized management strategies, is essential for improving long-term outcomes in this high-risk population.